Another Reddit Choice? TLRY..18.56 Up 8% Cannabis Being heavily talked about on Reddit ..Volume very heavy.. Watch it.
FISKER STOCK IS A STRONG ELECTRIC VEHICLE PLAY FOR PATIENT INVESTOR FSR..13.37 One year before Ocean SUV rolls off assembly line Slow and Steady Progress Reservation Numbers were 12,000 now raised to 16,000 Vehicles TipRanks Moderate buy with Target Price 24.70 BOTTOM LINE FISKER IS A STRONG LONG TERM PLAY
Bearish To Bull?ZOM...8210..Zomedica Did reach 2.59 in March Provider of Vetrinary diagnostic products.. Truforma Platform which can diagnose adrenal and thyroid health in domestic animals.. Company undergoing sales effort to get Truforma in the hands of as many Vets as possible.
Underpriced EVFM..86...Evofem Biosciences Innovative products for women's health needs..Reproductive health and sexual health products .. Last week closed on 50 million closed offering One FDA appoved product Working on new product for use preventing urogenital Chlamydia and gonorrhoeae in women. Was a 5.00 stock in Feb.. Forecast to grow 352% per yearcompared to US Bio-tech average of 52% TipRanks Moderate Buy with Target price 7.00
Could Be A Permanent Swing In Your Yard EEGI..Down Friday 14% .0063 Average Daily volume 600 million Last two week Variance Low...0030 High .0097
HEXO..7.18 Hexo Corp announced the acquisition of Redecan to create Canadian Market Leader in Adult Use Sales Hexo is an Award winning consumer packaged goods cannabis company that creates and distributes innovative products to serve the global cannabis market Revenue has grown faster 301% than US Industry average of 16% Revenue forescast to grow 59% per year StockTA Bullish Short Barchart Buy
June Cannabis Play VFF..9.75..Village Farms The Company operates business through segments that are Cannabis..Produce and Energy Cannabis segment produce and supplies cannabis products to other licensed providers and provincial governments across Canada and Internationally Considered undervalued Return on Equity forecast to be 40% in four years Earnings projected to grow 197% per year Revenue projected to be 31% per year compared to US Farm Industry average of 5% Reached a high of 19.71 in Feb.. Investopedia and Motley Fool buys TipRanks Strong Buy with Target Price of 18.08
Keep An Eye On This One EYES..5.98..Secon Sight Medical Products Developes, manufactures, and markets implantable visual prosthetics for delivering artificial vision to the blind. Positive Clinical Trial Results on its Visual Cortical Prothesis. Float 17.96 million Target price 10.00
This Bio-Pharm Could Be In Bright Lights At year's End AXSM..60.71..Axesome Therapeutics Lead candidate AXS-05 targets depression and Alzheimer's disease-related agitation.. Developing experimental migraine drug AXS-07 seeking FDA approval second quarter 2021.. If approved AXS-07 as a depression treatment could be a blockbuster drug..Sales est at 2.6 Billion Market Cap 2.2 Billion Float 29 million Return on Equity projected to be 336% in four years Forecast to generate higher Return on Assets 194% than US Industry average of 10% 257 Financial Institutions holding shares..Vanguard 2.6 million...Blackrock 2.3 million TipRanks Strong buy with Target price 135.83
EXEL..22.55Exelixis Reported Encouraging Data From Prostate Cancer Study Profitable lead cancer drug Cabometyx looks to be on tis way to 1 Billion Dollar in Sales no later than 2022 Cabometyz is also being studies in close to six dozen additional cancer trials Considered Undervalued 7 Billion Market CapHeld by 501 Financial Institutions..Blackrock holds 32 million shares..Vanguard 29 million and Price T Rowe 20 million Ended March with 1.6 Billion in Cash and Cash Equivalents Projected Return on Equity 36% in four years Revenue Forecast To Grow 24% per year Earnings Forecast To Grow 88% compared to US Industry average of 24% Barchart Buy Tipranks Moderate Buy with Target Price of 30.57
One To Watch This Week AGEN..4.26..Agenus AGEN-2373 Cervical Cancer Drug Early data showed drug was well tolerated in dose escalation trial..Suggested the combination had tumor-killing potential superior to current commercially available antibodies.. Blackrock owns 14 million shares Return on Equity has been 94% Return on Equity projected to be 62% in four years Revenue Forecast To Grow 27% per year StockTA Bullish Short and Long TipRanks Strong Buy with Target Price of 7.50
Goldman Sachs Upgrade To Buy STEM..25.34 Delivers and operates battery storage solutions that maximize renewable energy generation and helps build a cleaner and more resilient grid Thanks to artificial intelligence and machine learning companies utilizing Stem's technology they save up to 30% on energy bills. Operates in four Countries..Nine States and two hundred cities Has 950 Systems in place Stem will be on the forefront of clean energy storage expansion Market Cap 3.1 billion Float 15.5 million Held by 119 Financial Institutions A Financhill recommended Buy StockTA Bullish Short and Very Bullish Long TipRanks Moderate Buy Target price 30.60
Markets Closed Today AMC..Tomorrow..Up..Down..Sideways Well if German markets are any indication AMC Up this morning 12%..24.90
News Out This Morning WDDMF...2404 WEEDMD Net Revenue increased 41% year over year to 29.4 million Kilograms harvested in 2020 grew 88% over prior year to 33,751 with more grad A Flower Preliminary unaudited Q2021 gross revenue of 12 million represents 40% growth in high-margin direct-to-consumer patient sales when compared to prior year up 72% from Q42020 WeedMD and privately Owned CannTX Life Sciences Just Signed Letter Of Intent to Create a Cannabis Cultivation and Consumer-Centric Product Portfolio Analysts Average price Target .60
Guaranteed Not To Go Up In Smoke CRLBF..12.25..Cresco Labs Sells Retail and Medical Cannabis Products Delivered Revenue of 178 million...168% yearover year increase and beating estimates by 7.02 million Adjusted EBITDA came in at 35 million more than sixfold improvement on the same period last year and a 16.5% increase from previous quarter By the end of year Company expects to have annualized run rate of more than 1 billion and forecasts gross profit margin of over 50% rest of 2021 Market Cap 2.7 billion A Wallet Investor Awesome Buy and Hold One year forecast 19.95 Five year forecast 52.18 TipRanks Strong buy Target price 21.52
RZLT..10.33..Rezolute Bio-pharm specializes in developing drug therapies new medications for patients with difficult to treat metabolic conditions. Two pipeline drugs RZ358 treatment for congenital hyperinsulism 32 million in cash and equivalents Despite assets with promising data..Rezolute has been overlooked by investment community Very Low Float 4.27 million Considered Significantly Undervalued Financhill rates it a 74 out of 100 Wallet Investor Good Buy and Hold Five year forecast 35.05 TipRanks Strong Buy with Target price of 25.33
WPRT...6.26 Westport Fuel Systemsoperates in green sector of the energy and transportation industry.producing natural gas engines and associated fuel system components, both personal and commercial vehicles Has 1,400 patents and patent applications Last year made sales in 70 Countries Revenue of 252 million Focusing on driving growth in North America Return on Equity 63% in four years Revenue Forecast To Grow 23% per year Earning Forecast To Grow 94% per year TipRanks Strong Buy Target price 13.33
